Figure 1
Structures of (A) 2-(4-amino-3-methylphenyl)benzothiazole (R=H; DF 203; NSC 674495), 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (R=F; 5F 203, NSC 703786) and (B) the lysylamide dihydrochloride salt of 5F 203 (Phortress, NSC 710305).
Figure 1 | British Journal of Cancer
